Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes,...
Fineline Cube
Haisco’s HSK16149 Accepted for Review by NMPA for Diabetic Neuropathic Pain
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that a market approval filing...
Cowell Health Partners with AstraZeneca to Enhance Cancer Care at CIIE
Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th...
Liaoning Chengda’s ACYW135 Meningococcal Vaccine Receives NMPA Clearance
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) has announced that it has received clinical...
Zhaoke Ophthalmology Enrolls First Patients for ZKY001 in Phase II Trials
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
CDE Seeks Public Feedback on New Drug Benefit-Risk Assessment Guidelines
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
Zhaoke Ophthalmology Licenses C&V Tech’s TONO-i Tonometer for Greater China
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
CDE Releases Draft Guidelines on New Drug Benefit-Risk Assessment
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
Insilico Medicine Partners with Sanofi for AI-Driven Drug Discovery
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company based in Hong Kong, has announced...
CDE Releases Guidelines on Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a Technical Guidelines document focused on “Clinical...
Pfizer Partners with CARD, CSAF, and PingAn Good Doctor at CIIE
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between US-based...
Pfizer China Partners with Alibaba Health for Disease Education at CIIE
The 5th China International Import Expo (CIIE) saw US-based Pfizer’s China unit announce a partnership...
Adicon Partners with Illumina to Advance Oncology Detection Assay TSO 500
China-based Adicon Holdings Limited has announced a strategic partnership with US-based Illumina (NASDAQ: ILMN) at...
Pfizer Partners with China Cardiovascular Association to Tackle Heart Failure
US-based Pfizer (NYSE: PFE) has initiated a strategic partnership with the China Cardiovascular Association (CCA),...
Pfizer Partners with China Cardiovascular Association to Tackle Heart Failure
US-based Pfizer (NYSE: PFE) has initiated a strategic partnership with the China Cardiovascular Association (CCA),...
MicuRx Pharmaceuticals Doses First Patient in China for MRX-8 Trial
Shanghai-based antibacterial drug developer MicuRx Pharmaceuticals (SHA: 688373) has announced the first patient dosing in...
Zhifei Bio Initiates Global Study for Omicron-Delta COVID-19 Vaccine in Uzbekistan
China-based Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd has announced the initiation of a global clinical study...
Mainline Biosciences Raises RMB 100M in Series A Financing for Peptide Drugs
Mainline Biosciences, a polypeptide drug developer based in Zhongshan, has reportedly raised close to RMB...
Jiangsu Trausim Raises RMB 100M in Series A Financing for Dental Implants
China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused...
Cyramza Prescribed in China for Advanced Gastric Cancer
Cyramza (ramucirumab) was first prescribed on November 6, 2022, at the Zhongshan Hospital in Shanghai...